7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, JC; Hsieh, YT; Kuo, YH; Lao, CL | 1 |
1 other study(ies) available for 7-hydroxy-2-n,n-dipropylaminotetralin and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Intranasal and subcutaneous administration of dopamine D3 receptor agonists functionally restores nigrostriatal dopamine in MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Intranasal; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopaminergic Neurons; Gait; Indoles; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MPTP Poisoning; Receptors, Dopamine D3; Substantia Nigra; Tetrahydronaphthalenes | 2013 |